Manufacturer record
Swiss India Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Swiss India Laboratories (Himachal Pradesh) was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T3-13, Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin Syrup (exp Mar 2027). DTL, Delhi (state lab) found it not of standard quality: TESTS FOR ASSAY (CONTENT) OF AMBROXOL HYDROCHLORIDE. Listed in the September 2026 alert.
Records by type
1 record linked to Swiss India Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin Syrup | Batch T3-13Mfg Apr 2025 · Exp Mar 2027 | TESTS FOR ASSAY (CONTENT) OF AMBROXOL HYDROCHLORIDEAssay | DTL, DelhiState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.